CC
LLY icon

Codex Capital’s Eli Lilly LLY Stock Holding History

Codex Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$13.2M Sell
17,000
-1,000
-6% -$712K 6.45% 4
2023
Q4 		$10.5M Sell
18,000
-150
-0.8% -$87.6K 6.12% 3
2023
Q3 		$9.75M Hold
18,150
– – 6.29% 3
2023
Q2 		$8.51M Sell
18,150
-850
-4% -$356K 5.48% 3
2023
Q1 		$6.52M Hold
19,000
– – 4.5% 6
2022
Q4 		$6.95M Hold
19,000
– – 5.81% 3
2022
Q3 		$6.14M Buy
19,000
+3,000
+19% +$951K 5.26% 4
2022
Q2 		$4.58M Hold
16,000
– – 2.8% 17
2022
Q1 		$4.58M Buy
16,000
+14,200
+789% +$3.65M 2.82% 17
2021
Q4 		$497K Hold
1,800
– – 0.26% 37
2021
Q3 		$416K Hold
1,800
– – 0.22% 37
2021
Q2 		$412K Buy
+1,800
New +$362K 0.22% 37

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Codex Capital's LLY Position: Q1 2024 in Review

Codex Capital reduced its Eli Lilly (LLY) stake by 5.6% in Q1 2024, selling an estimated $712K and leaving 17,000 shares worth $13.2M. The position accounts for 6.45% of the portfolio, ranked #4.

Codex Capital first reported a position in LLY in Q2 2021 and has held it in 12 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Codex Capital held 17,000 shares of Eli Lilly worth $13.2M as of Q1 2024.
  • Codex Capital sold 1,000 Eli Lilly shares in Q1 2024, an estimated $712K.
  • Eli Lilly made up 6.45% of Codex Capital's portfolio in Q1 2024, its #4 holding.
  • Codex Capital first reported a position in Eli Lilly in Q2 2021 and has held it in 12 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Codex Capital's 13F filing for Q1 2024, filed 7 May 2024.